Digital Cognitive Behavioral Therapy for Insomnia in Cancer Pain Patients: Protocol for a Prospective, Randomized Controlled Trial
Open Access
- 1 December 2025
- journal article
- research article
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 18, 7053-7063
Abstract
Introduction: Insomnia is one of the most common complications in cancer patients, and Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment for insomnia in the general population and patients with a cancer diagnosis. Traditional CBT-I is susceptible to limitations such as geography, physical condition, and cost of access to healthcare, hindering its widespread adoption. With the application and development of digitalization and artificial intelligence providing opportunities for the administration and promotion of Digital Cognitive Behavioral Therapy for Insomnia (DCBT-I) to provide a better sleep treatment option for cancer pain patients, this study aims to evaluate its efficacy. Methods: This single-center trial will randomize 158 cancer pain patients with insomnia to DCBT-I or sleep hygiene education (1:1) to test if DCBT-I is superior for improving sleep quality. Assessments will also cover pain intensity, mental health, and quality of life. Discussion: This study will provide valuable clinical evidence that DCBT-I helps to improve sleep quality, pain intensity, mental health, and quality of life in cancer pain patients suffering from insomnia and contributes to the dissemination of this non-pharmacological alternative treatment option. Conclusion: This study protocol outlines a rigorous randomized controlled trial to evaluate the efficacy of Digital Cognitive Behavioral Therapy for Insomnia (DCBT-I) compared to Sleep Hygiene Education (SHE) in cancer pain patients with comorbid insomnia. The Resleep smartphone-based intervention integrates evidence-based CBT-I components (sleep restriction, stimulus control, cognitive restructuring, and relaxation training) to address the limitations of traditional therapy, such as accessibility and cost. Clinical Trial Registration: This study is a registered clinical trial. Registry: Chinese Clinical Trial Registry (ChiCTR), listed in the WHO International Clinical Trials Registry Platform (WHO ICTRP). Trial Registration Number: ChiCTR2500096855. Date of Registration: 07 February 2025. Registration Url: https://www.chictr.org.cn/index.html.Keywords
This publication has 22 references indexed in Scilit:
- Dysfunctional beliefs and attitudes about sleep (DBAS) mediate outcomes in dCBT-I on psychological distress, fatigue, and insomnia severitySleep Medicine, 2023
- Digital Cognitive Behavioral Therapy for Insomnia Using a Smartphone Application in ChinaJAMA Network Open, 2023
- Quality of life in thyroid cancerBest Practice & Research Clinical Endocrinology & Metabolism, 2023
- Pain-related beliefs about sleep as a predictor of insomnia symptoms and treatment acceptabilitySleep Medicine, 2022
- Improved resilience following digital cognitive behavioral therapy for insomnia protects against insomnia and depression one year laterPsychological Medicine, 2022
- Systematic review and meta-analysis of cognitive-behavioural therapy for insomnia on subjective and actigraphy-measured sleep and comorbid symptoms in cancer survivorsSleep Medicine Reviews, 2022
- Sleep disorders and cancer: State of the art and future perspectivesSleep Medicine Reviews, 2021
- Efficacy of digital cognitive behavioural therapy for insomnia: a meta-analysis of randomised controlled trialsSleep Medicine, 2020
- Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients?Psycho-Oncology, 2014
- Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment.Health Psychology, 2014